Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer

This study has been completed.
Information provided by (Responsible Party):
University of New Mexico Identifier:
First received: February 28, 2006
Last updated: May 10, 2016
Last verified: May 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: February 2008 (Final data collection date for primary outcome measure)